Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia.

Serum lipids and coronary heart disease in heterozygous familial hypercholesterolemia in the Hokuriku District of Japan.

The Tromsø Heart Study: serum apolipoprotein AI concentration in relation to future coronary heart disease.

Lipoprotein (a) and coronary heart disease in patients with familial hypercholesterolemia.

Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes.

Achilles tendon thickness and ischemic heart disease in familial hypercholesterolemia.

Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach.

Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease.

Relation of infant feeding to adult serum cholesterol concentration and death from ischaemic heart disease.

Genetic and environmental variation in serum lipoproteins in relation to coronary heart disease.

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.

Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.

Serum apolipoproteins in heterozygous familial hypercholesterolemia.

Early development of xanthoma and coronary disease in a young female with homozygous familial hypercholesterolemia.

Genetic markers of familial coronary heart disease.

Extensive xanthomas with severe coronary artery disease in a young patient with familial hypercholesterolemia.

Relation of left atrial dysfunction to ischemic stroke in patients with coronary heart disease (from the heart and soul study).

Plasma high-density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia.

A study in familial hypercholesterolemia suggests reduced methylomic plasticity in men with coronary artery disease.

Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease.

The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.

Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia.

Relation between serum calcium levels and mortality in patients with coronary artery disease.

Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia.

A clinical study of patients with coronary heart disease complicated with hypertriglyceridemic waist phenotype.

Suggest Documents

Serum lipids and coronary heart disease in heterozygous familial hypercholesterolemia in the Hokuriku District of Japan.

The Tromsø Heart Study: serum apolipoprotein AI concentration in relation to future coronary heart disease.

Lipoprotein (a) and coronary heart disease in patients with familial hypercholesterolemia.

Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes.

Achilles tendon thickness and ischemic heart disease in familial hypercholesterolemia.

Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach.

Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease.

Relation of infant feeding to adult serum cholesterol concentration and death from ischaemic heart disease.

Genetic and environmental variation in serum lipoproteins in relation to coronary heart disease.

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.

Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.

Serum apolipoproteins in heterozygous familial hypercholesterolemia.

Early development of xanthoma and coronary disease in a young female with homozygous familial hypercholesterolemia.

Genetic markers of familial coronary heart disease.

Extensive xanthomas with severe coronary artery disease in a young patient with familial hypercholesterolemia.

Relation of left atrial dysfunction to ischemic stroke in patients with coronary heart disease (from the heart and soul study).

Plasma high-density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia.

A study in familial hypercholesterolemia suggests reduced methylomic plasticity in men with coronary artery disease.

Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease.

The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.

Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia.

Relation between serum calcium levels and mortality in patients with coronary artery disease.

Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia.

A clinical study of patients with coronary heart disease complicated with hypertriglyceridemic waist phenotype.

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia.

Recommend Documents

Follow Us